Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics.

@article{Geier2007InflammatoryBD,
  title={Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics.},
  author={Mark S. Geier and Ross N. Butler and Gordon Stanley Howarth},
  journal={International journal of food microbiology},
  year={2007},
  volume={115 1},
  pages={1-11}
}
Inflammatory bowel disease (IBD) is a chronic relapsing disorder involving a dysregulated host-microbiota interaction. IBD patients have been shown to possess an increased risk for the development of colorectal cancer. Recently, focus has been placed on probiotic and prebiotic therapies, which aim to restore balance to the gastrointestinal microbiota, and reduce intestinal inflammation. Probiotics have been assessed extensively in animal models, with a number of clinical trials also… CONTINUE READING

Citations

Publications citing this paper.

Similar Papers

Loading similar papers…